Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Iniparib |
| Trade Name | |
| Synonyms | BSI-201|SAR240550 |
| Drug Descriptions |
Iniparib (BSI-201) appears to modify cysteine-containing proteins in tumor cells, and has minimal activity as a PARP inhibitor (PMID: 22128301, PMID: 22291137, PMID: 31172407, PMID: 30131387). |
| DrugClasses | |
| CAS Registry Number | 160003-66-7 |
| NCIT ID | C62526 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| AsiDNA + Iniparib | AsiDNA Iniparib | 0 | 0 |
| Carboplatin + Doxorubicin + Iniparib | Carboplatin Doxorubicin Iniparib | 0 | 1 |
| Carboplatin + Gemcitabine + Iniparib | Carboplatin Gemcitabine Iniparib | 0 | 1 |
| Iniparib | Iniparib | 0 | 1 |
| Iniparib + Irinotecan | Iniparib Irinotecan | 0 | 1 |
| Iniparib + Paclitaxel | Iniparib Paclitaxel | 0 | 1 |
| Iniparib + Radiotherapy + Temozolomide | Iniparib Radiotherapy Temozolomide | 0 | 0 |
| Iniparib + Topotecan | Iniparib Topotecan | 0 | 1 |